GlobalData on MSN
Pilatus Biosciences doses first patient in PLT012 antibody trial
The study will assess the tolerability, safety, maximum tolerated dose, and the recommended Phase II dose of PLT012.
While the whole world is more and more enamored of AI and all its applications, there exist some very real barriers impeding its full success. Take, for example, AI data center infrastructure, which ...
AN investigation has been launched after a cluster of people were struck down by a deadly lung disease that spreads in dirty ...
Scientists have detected a surprisingly hot galaxy cluster dating back to the universe’s infancy. The cluster formed far earlier and burned far hotter than current models predict. Researchers believe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results